Abstract

BackgroundAlthough non-alcoholic fatty liver disease (NAFLD) is considered to be associated with chronic kidney disease (CKD), long-term follow up data is lacking. We investigated whether NAFLD, as determined by the fatty liver index (FLI), could predict incident CKD in 10-year prospective cohort study. We also assessed the clinical utility of FLI to predict the development of CKD.Methods6,238 adults aged 40 to 69 years without baseline CKD from the Ansan—Ansung cohort were examined. Patients were classified according to FLI as follows: FLI<30, no NAFLD; FLI≥60, NAFLD; and 30≤ FLI<60, intermediate. Incident CKD was defined as estimated glomerular filtration rate (eGFR) <60 ml/min per 1.73 m2. The clinical utility of FLI in predicting incident CKD was estimated via area under the receiver-operating characteristic curve (AUC), net reclassification improvement (NRI), and integrated discrimination improvement (IDI) analyses.ResultsDuring an average of 10 years of follow-up, 724 subjects (15.21%) developed CKD. The adjusted hazard ratio [95% confidence interval (CI)] for incident CKD increased in a graded manner with FLI increased (<30 vs. 30–59 vs. ≥60 = 1 vs. 1.17 [0.997–1.375] vs. 1.459 [1.189–1.791], respectively, P for trend = 0.0012). Incorporation of FLI into traditional risk factors of CKD significantly increased prediction of incident CKD based on NRI (17%; 95% CI, 8.9–25%; P-value <0.001) and IDI (0.002; 95% CI, 0.0046–0.0143; P-value = 0.046).ConclusionsFLI, a surrogate marker of NAFLD, was an independent risk factor for incident CKD. FLI provides meaningful incremental risk reclassification beyond that of conventional risk factors of CKD.

Highlights

  • Chronic kidney disease (CKD) has become a worldwide health problem that results in high morbidity and mortality in various chronic diseases, consuming substantial healthcare costs

  • We investigated whether Non-alcoholic fatty liver disease (NAFLD), as determined by the fatty liver index (FLI), could predict incident CKD in 10-year prospective cohort study

  • The adjusted hazard ratio [95% confidence interval (CI)] for incident CKD increased in a graded manner with FLI increased (

Read more

Summary

Introduction

Chronic kidney disease (CKD) has become a worldwide health problem that results in high morbidity and mortality in various chronic diseases, consuming substantial healthcare costs. CKD has come to be considered a risk factor for end-stage renal disease, and cardiovascular disease, even in the early stages of renal dysfunction. Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease, with a prevalence as high as 30% of the general population in developed countries [4]. NAFLD is considered to be a risk factor for type 2 diabetes, insulin resistance, and cardiovascular disease [7,8], and there is growing evidence to support it as a cause of incident CKD [9]. Non-alcoholic fatty liver disease (NAFLD) is considered to be associated with chronic kidney disease (CKD), long-term follow up data is lacking. We assessed the clinical utility of FLI to predict the development of CKD.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call